Observational Study for Left Main Disease Treatment
ConditionCoronary Artery Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSeung-Jung Park
About this trial
The purpose of this study is to observe clinical courses for long-term in patients with unprotected LMCA disease and to evaluate comparative results of medical treatment, coronary stenting with drug-eluting stents, and CABG for the treatment of an unprotected LMCA stenosis in the "real world" daily practice.
Eligibility criteria
Qualifiers
Significant unprotected left main stenosis (>50% by visual estimation)
The LMCA is considered unprotected if there are no patent coronary artery bypass grafts to the left anterior descending artery or the left circumflex artery.
No limitation of clinical or lesion characteristics
Age >18 years
Disqualifiers
Protected left main stenosis
Trial design
Treatments tested in this trial
- Not listed
Trial groups
10,000 Participants
are grouped into 1 trial groupSponsors and collaborators
Seung-Jung Park
Lead sponsor
CardioVascular Research Foundation, Korea
Sponsor institution
CardioVascular Research Foundation, Korea
Collaborator
Source ClinicalTrials.gov